These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6620572)

  • 1. [Partial laryngectomy following combined FAR therapy--evaluation of survival rate and region of recurrence studied by an antomical map].
    Watanabe H; Komiyama S; Tomita K; Jinguh K
    Gan No Rinsho; 1983 Aug; 29(9):945-8. PubMed ID: 6620572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of treatment on laryngeal cancer].
    Komiyama S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1204-9. PubMed ID: 6732249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
    Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
    Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China.
    Ji W; Guan C; Pan Z
    Acta Otolaryngol; 2008 May; 128(5):574-7. PubMed ID: 18421614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
    Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after partial frontolateral laryngectomy.
    Dedivitis RA; Guimarães AV; Guirado CR
    Int Surg; 2005; 90(2):113-8. PubMed ID: 16119718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patient selection for near-total laryngectomy and oncologic results].
    Ozüdoğru E; Cingi E; Cakli H; Keçik MC; Cingi C; Gürbüz MK
    Kulak Burun Bogaz Ihtis Derg; 2002; 9(2):121-5. PubMed ID: 12122633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic vertical partial laryngectomy.
    Davis RK; Hadley K; Smith ME
    Laryngoscope; 2004 Feb; 114(2):236-40. PubMed ID: 14755197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of indications for reoperations after combined treatment of laryngeal cancer with function preserving surgery at the second stage].
    Bitiutskiĭ PG; Trofimov EI
    Vestn Otorinolaringol; 1993; (4):16-9. PubMed ID: 8036752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
    Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
    Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Partial laryngectomy plus radiotherapy versus partial laryngectomy alone for laryngeal carcinoma].
    Zeng Z; Chen F; Zhang Q; Yang A; Zeng X; Cheng W; Guo Z; Xu G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Feb; 35(1):32-4. PubMed ID: 12768686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "FAR" chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma.
    Kumamoto Y; Masuda M; Kuratomi Y; Toh S; Shinokuma A; Chujo K; Yamamoto T; Komiyama S
    Head Neck; 2002 Jul; 24(7):637-42. PubMed ID: 12112536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrence after vertical partial laryngectomy, a conservative modality of treatment for patients with Stage I-II squamous cell carcinoma of the glottis.
    Laccourreye O; Gutierrez-Fonseca R; Garcia D; Hans S; Hacquart N; Ménard M; Brasnu D
    Cancer; 1999 Jun; 85(12):2549-56. PubMed ID: 10375101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
    Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
    Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.